Daniel N. Cortright

4.2k citations

33 papers · 3.3k indexed · 2 hit papers · h-index 23

Impact in

Sensory Systems top 0.1%
- Ion Channels and Receptors
Behavioral Neuroscience top 2%

Papers in

Sensory Systems 17
- Ion Channels and Receptors 17
Behavioral Neuroscience 7
- Stress Responses and Cortisol 7

Co-authors: A Szállaśi James E. Krause Samer R. Eid Charles A. Blum Peter M. Blumberg Robert Elde Athena Guo Éva Mezey
Journals: Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Pharmacology and Experimental Therapeutics (3 papers)Endocrinology (3 papers)Nature Reviews Drug Discovery (2 papers)Molecular Pharmacology (2 papers)
Partner nations: United States United Kingdom Malaysia

In The Last Decade

Daniel N. Cortright

33 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept 2007 · 689 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 Nature Reviews Drug Discovery
2000 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Daniel N. Cortright

Since Specialization

Citations

This map shows the geographic impact of Daniel N. Cortright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel N. Cortright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel N. Cortright more than expected).

Fields of papers citing papers by Daniel N. Cortright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel N. Cortright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel N. Cortright. The network helps show where Daniel N. Cortright may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Daniel N. Cortright, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daniel N. Cortright Line = papers co-authored together Daniel N. Cortright links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Locomotor Activity in a Novel Environment as a Test of Inflammatory Pain in Rats Methods in molecular biology ·David J. Matson, Daniel C. Broom, Daniel N. Cortright	2010	17
2	Pyrido[2,3-b]pyrazines, discovery of TRPV1 antagonists with reduced potential for the formation of reactive metabolites Bioorganic & Medicinal Chemistry Letters ·Kevin J. Hodgetts, Charles A. Blum, Timothy M. Caldwell, Rajagopal Bakthavatchalam, Xiaozhang Zheng, Полина Кляхина, James E. Krause, Daniel N. Cortright, Marci Crandall, Beth Murphy, Susan Boyce, A. Brian Jones, Bertrand L. Chenard	2010	10
3	C5a, But Not C3a, Increases VEGF Secretion in ARPE-19 Human Retinal Pigment Epithelial Cells Current Eye Research ·Daniel N. Cortright, Robin Meade, Stephen M. Waters, Bertrand L. Chenard, James E. Krause	2009	41
4	TRP Channels and Pain Current Pharmaceutical Design ·Daniel N. Cortright, A Szállaśi	2009	111
5	Transient Receptor Potential Channels on Sensory Nerves Handbook of experimental pharmacology ·Samer R. Eid, Daniel N. Cortright	2009	51
6	Aminoquinazolines as TRPV1 antagonists: Modulation of drug-like properties through the exploration of 2-position substitution Bioorganic & Medicinal Chemistry Letters ·Charles A. Blum, Xiaozhang Zheng, Harry L. Brielmann, Kevin J. Hodgetts, Rajagopal Bakthavatchalam, Jayaraman Chandrasekhar, James E. Krause, Daniel N. Cortright, David J. Matson, Marci Crandall, Pei‐Chia Huang, Lawrence K. Fung, Karlo Stastny, Mark T. Kershaw, Stéphane De Lombaert, Bertrand L. Chenard	2008	13
7	Characterization of N-(Adamantan-1-ylmethyl)-5-[(3 R-aminopyrrolidin-1-yl)methyl]-2-chloro-benzamide, a P2X7 Antagonist in Animal Models of Pain and Inflammation Journal of Pharmacology and Experimental Therapeutics ·Daniel C. Broom, David J. Matson, Elizabeth M. Bradshaw, Marianne E. Buck, Robin Meade, T. Maeser, Kathryn H. Chace, Boulakroune Abderrahmane, Weifeng Yu, Jun Yuan, Synthia H. Sun, Ricardo Ochoa, James E. Krause, David J. Wustrow, Daniel N. Cortright	2008	67
8	New frontiers in assessing pain and analgesia in laboratory animals Expert Opinion on Drug Discovery ·Daniel N. Cortright, David J. Matson, Daniel C. Broom	2008	13
9	1-Benzylbenzimidazoles: The discovery of a novel series of bradykinin B1 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·W. Ray Rhine, Jayaraman Chandrasekhar, David C. Ihle, David J. Wustrow, Bertrand L. Chenard, James E. Krause, Alan Hutchison, Dr Alka VYAS, Ш. А. Мазанаев, Daniel N. Cortright, Daniel C. Broom, Mark T. Kershaw, Avery Lord, Yao Peng, Kevin J. Hodgetts	2008	9
10	Identification and Characterization of NDT 9513727 [N,N-bis(1,3-Benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1 H-imidazole-5-methanamine], a Novel, Orally Bioavailable C5a Receptor Inverse Agonist Journal of Pharmacology and Experimental Therapeutics ·Robbin Brodbeck, Daniel N. Cortright, Kiran Phuyal, Jianying Yu, G Enckell, Marianne E. Buck, Robin Meade, George D. Maynard, Andrew Thurkauf, Du‐Shieng Chien, Alan Hutchison, James E. Krause	2008	27
11	TRP channels and pain Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Daniel N. Cortright, James E. Krause, Daniel C. Broom	2007	90
12	The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept Nature Reviews Drug Discovery ·A Szállaśi, Daniel N. Cortright, Charles A. Blum, Samer R. Eid Hit paper breakdown →	2007	689
13	Biochemical pharmacology of the vanilloid receptor TRPV1 European Journal of Biochemistry ·Daniel N. Cortright, A Szállaśi	2004	254
14	Formalin- or adjuvant-induced peripheral inflammation increases neurokinin-1 receptor gene expression in the mouse Brain Research ·A Allen, Daniel N. Cortright, Kenneth E. McCarson	2003	15
15	Biochemical characterization and expression analysis of the Xenopus laevis corticotropin-releasing hormone binding protein Molecular and Cellular Endocrinology ·Roldán A. Valverde, Audrey F. Seasholtz, Daniel N. Cortright, Robert J. Denver	2001	34
16	The Tissue Distribution and Functional Characterization of Human VR1 Biochemical and Biophysical Research Communications ·Daniel N. Cortright, Marci Crandall, 雅刘, Tong Zou, James E. Krause, Geoffrey White	2001	81
17	The distribution and regulation of vanilloid receptor VR1 and VR1 5′ splice variant RNA expression in rat Neuroscience ·雅刘, James E. Krause, Daniel N. Cortright	2001	128
18	Substance P and neurokinin-1 receptor expression by intrinsic airway neurons in the rat American Journal of Physiology-Lung Cellular and Molecular Physiology ·J. Fontan, Daniel N. Cortright, James E. Krause, Richard Almond, G Grateau, Terry W. Carver, Steven D. Shapiro, Bassem N. Mora	2000	36
19	The Cloned Rat Vanilloid Receptor VR1 Mediates Both R-Type Binding and C-Type Calcium Response in Dorsal Root Ganglion Neurons Molecular Pharmacology ·A Szállaśi, Peter M. Blumberg, Wei-You, James E. Krause, Daniel N. Cortright	1999	105
20	Resiniferatoxin‐type phorboid vanilloids display capsaicin‐like selectivity at native vanilloid receptors on rat DRG neurons and at the cloned vanilloid receptor VR1 British Journal of Pharmacology ·A Szállaśi, Tamás Szabó, Tamás Bı́ró, Shayan Modarres, Peter M. Blumberg, James E. Krause, Daniel N. Cortright, Giovanni Appendino	1999	58

About Daniel N. Cortright

Daniel N. Cortright is a scholar working on Sensory Systems, Behavioral Neuroscience, Cellular and Molecular Neuroscience, Physiology and Complementary and alternative medicine, having authored 33 papers that have together received 3.3k indexed citations. Recurring topics across this work include Ion Channels and Receptors (17 papers), Pain Mechanisms and Treatments (15 papers), Stress Responses and Cortisol (7 papers), Neurobiology and Insect Physiology Research (6 papers), Neuropeptides and Animal Physiology (6 papers), Herbal Medicine Research Studies (5 papers), Ion channel regulation and function (3 papers) and Hormonal Regulation and Hypertension (3 papers). The work is most often cited by research in Sensory Systems (1.7k citations), Behavioral Neuroscience (217 citations), Physiology (1.5k citations), Cellular and Molecular Neuroscience (945 citations) and Complementary and alternative medicine (333 citations). Daniel N. Cortright has collaborated with scholars based in United States, United Kingdom and Malaysia. Frequent co-authors include A Szállaśi, James E. Krause, Samer R. Eid, Charles A. Blum, Peter M. Blumberg, Robert Elde, Athena Guo, Éva Mezey, Zsuzsanna Tóth and Audrey F. Seasholtz. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Pharmacology and Experimental Therapeutics, Endocrinology, Nature Reviews Drug Discovery and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact